Cha1 Treatment for Triple Negative Breast Cancer - Francesca Deleso-Frechette
Tufts-Laidlaw Scholar Francesca Deleso-Frechette's research talk on Cha1 Treatment for Triple Negative Breast Cancer.
Published
Tufts-Laidlaw Scholar Francesca Deleso-Frechette's research talk on Cha1 Treatment for Triple Negative Breast Cancer.
Tufts-Laidlaw Scholar Francesca Deleso-Frechette's research talk on
Cha1 Treatment for Triple Negative Breast Cancer.
Recorded: Tufts - Robinson 253 - October 19th, 2019
Administrator, Office of the Provost, Tufts University
As Lord Laidlaw, our Chairman, and Susanna Kempe, our CEO, met with scholars and alumni from around the world, many requested a way to meet ambitious peers, participate in leadership-in-action initiatives and collaborate on research projects for a better present. We welcome you to the Laidlaw Scholars Network, a social utility tool that allows you to do just this! Be the new generation of passionate, adaptive, ethical leaders.